GSK, United Kingdom
Disclosure information not submitted.
5D-06 - Automated Causality Assessments of Individual Case Safety Reports
Tuesday, August 26, 20259:45 AM - 10:00 AM ET
6D-10 - The usability of active comparator and propensity scores in pharmacovigilance signal detection studies with disproportionality analysis: An example of sodium-glucose cotransporter-2 inhibitors
Tuesday, August 26, 20252:35 PM - 2:40 PM ET
